# Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ

> **NCT00072462** · PHASE3 · COMPLETED · sponsor: **Queen Mary University of London** · enrollment: 2980 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** tamoxifen citrate
- **DRUG:** Anastrozole

## Key facts

- **NCT ID:** NCT00072462
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2015-12
- **Final completion:** 2021-05-31
- **Target enrollment:** 2980 (ACTUAL)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00072462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00072462, "Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00072462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*